Modified Dantien Salee Yoga Training Program in Chronic Obstructive Pulmonary Disease Rehabilitation

Not Applicable

• Conditions: Pulmonary Disease, Chronic Obstructive
• Interventions: Other: Modified Dantien Salee Yoga Training Program

• Registration Number: NCT02770677
• Lead Sponsor: Mahidol University

Brief Summary

COPD patients will be recruited and assigned into one of each group: 1) Control group or 2) Yoga group. In Yoga groups, subjected will be asked to participate in Modified Dantien Yoga training for 12 weeks (3 times/week, 60 min/time). The subjects will be evaluated their pulmonary function, functional fitness performance, dyspnea score, and quality of life at baseline and after 12 wk training.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2016-04-07
• Study First Submitted: 2016-04-20
• Study First Submitted QC: 2016-05-10
• Study First Posted: 2016-05-12
• Status Verified: 2019-08
• Last Update Submitted: 2019-08-14
• Last Update Posted: 2019-08-16
• Primary Completion: 2019-10-30
• Study Completion: 2019-10-30

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

1. Stable COPD patients > or equal 6 weeks.
2. Age > or equal 50-80 years.
3. FEV1 > or equal 30% predicted after take bronchodilators drug.
4. Resting SpO2 > or equal 90% room air.
5. Did not pulmonary rehabilitation program before start the yoga

Read More

Exclusion Criteria

1. Subjects with musculoskeletal disorders, mental and neurological disorders, and acute coronary heart disease.
2. Blood Pressure (systolic) > 180 mmHg.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Yoga group	Modified Dantien Salee Yoga Training Program	Yoga group will be exposed to Modified Dantien Salee Yoga Training Program for 12 weeks

Primary Outcome Measures

Name	Time	Method
Change from baseline MVV (Maximum Voluntary Ventilation) (L/min) at 12 weeks	12 weeks	Change of MVV (Maximum Voluntary Ventilation) (L/min) will be measured on a computerized Spirometer at the baseline and 12 weeks.
Change from baseline upper body flexibility assessed with Back Scratch test at 12 weeks	12 weeks.	Change from baseline upper body flexibility assessed with Back Scratch test (cm)
Change from baseline FEV1 (Forced Expiratory Volume in 1 minute)(L) at 12 weeks	12 weeks	Change of Forced Expiratory Volume in 1 second will be measured on a computerized Spirometer at the baseline and 12 weeks.
Change from baseline PEFR (Peak Expiratory Flow Rate) (L/sec) at 12 weeks	12 weeks	Change of MVV (Maximum Voluntary Ventilation) (L/sec) will be measured on a computerized Spirometer at the baseline and 12 weeks.
Change from baseline IC (Inspiratoy Capacity) (L) at 12 weeks	12 weeks	Change of IC (Inspiratoy Capacity) (L) will be measured on a computerized Spirometer at the baseline and 12 weeks.
Change from baseline FRC (Functional Residual Capacity) (L) at 12 weeks	12 weeks	Change of FRC (Functional Residual Capacity) (L) will be measured on a computerized Spirometer at the baseline and 12 weeks.
Change from baseline PE max (Maximal Expiratoy Pressure) (cm H2O) at 12 weeks	12 weeks	Change of PE max (Maximal Expiratoy Pressure) (cm H2O) will be measured on a computerized Spirometer at the baseline and 12 weeks.
Change from baseline agility/dynamic balance assessed with 8-foot Up and Go test at 12 weeks	12 weeks	Change from baseline agility/dynamic balance assessed with 8-foot Up and Go test (sec)
Change from baseline Exercise Capacity assessed with 6-minute walk test at 12 weeks	12 weeks	Change from baseline Exercise Capacity assessed with 6-minute walk test (meter)
Change from baseline FVC (Forced Vital Capacity) (L) at 12 weeks	12 weeks	Change of FVC (Forced Vital Capacity) will be measured on a computerized Spirometer at the baseline and 12 weeks.
Change from baseline TLC (Total Lung Capacity) (L) at 12 weeks	12 weeks	Change of TLC (Total Lung Capacity) (L) will be measured on a computerized Spirometer at the baseline and 12 weeks.
Change from baseline RV (Residual Volume) (L) at 12 weeks	12 weeks	Change of RV (Residual Volume) (L) will be measured on a computerized Spirometer at the baseline and 12 weeks.
Change from baseline DLCO (Diffusion capacity to carbon monoxide) (ml/mmHg/min) at 12 weeks	12 weeks	Change of DLCO (Diffusion capacity to carbon monoxide) (ml/mmHg/min) will be measured on a computerized Spirometer at the baseline and 12 weeks.
Change from baseline PI max (Maximal Inspiratoy Pressure) (cm H2O) at 12 weeks	12 weeks	Change of PI max (Maximal Inspiratoy Pressure) (cm H2O) will be measured on a computerized Spirometer at the baseline and 12 weeks.
Change from baseline FEV1/FVC % predicted at 12 weeks	12 weeks	Change of FEV1/FVC % Predicted (Percent Predicted of ratio of FEV1 and FVC) (% predicted) will be measured on a computerized Spirometer at the baseline and 12 weeks.
Change from baseline lower body strength assessed with Chair Standing test at 12 weeks	12 weeks	Change from baseline lower body strength assessed with Chair standing test. ( time/30 sec)
Change from baseline upper body strength assessed with Arm curl test at 12 weeks	12 weeks	Change from baseline upper body strength assessed with Arm curl test (time/30 sec)
Change from baseline lower body flexibility assessed with Chair Sit and Reach test at 12 weeks	12 weeks	Change from baseline lower body flexibility assessed with Chair Sit and Reach test (cm)

Secondary Outcome Measures

Name	Time	Method
Change from baseline Dyspnea score assessed with visual analog scale at 12 weeks	12 weeks	Dyspnea or shortness of breath will be measured by visual analog scale (VAS) 1-10 point scale at the baseline and 12 weeks.
Change from baseline Quality of life score assessed with St. George's respiratory Questionnaires (SGRQ) at 12 weeks.	12 weeks	Change from baseline Quality of Life score assessed with St. George's respiratory Questionnaires (SGRQ) in Thai version at 12 weeks.

Trial Locations

Locations (1)

Faculty of Medicine, Siriraj Hospital; 🇹🇭 Bangkoknoi, Bangkok, Thailand